Pharmaceutical compositions
AssigneeBeecham Group Limited
InventorPatrick J. Crowley
Life of this patent
Estimating the term…
Abstract
A dry unit-dose pharmaceutical composition suitable for oral administration which composition comprises 20 mg to 1500 mg of amoxycillin trihydrate, 20 mg to 500 mg of potassium clavulanate and a pharmaceutically acceptable carrier with the proviso that the weight ratio of amoxycillin trihydrate to potassium clavulanate is from 6:1 to 1:1; has favored storage properties. Such compositions are presented in enclosed containers which they also contain a desiccant.
Claims4
A process for the production of a dry unit-dosage pharmaceutical composition suitable for oral administration each dosage unit of which comprises 20 mg to 1500 mg of amoxycillin trihydrate, 20 mg to 500 mg of potassium clavulanate and a pharmaceutically acceptable carrier, which comprises mixing potassium clavulanate and amoxycillin trihydrate in a weight ratio of 1:5 to 1:2 with a pharmaceutically acceptable carrier in an atmosphere containing less than 30% relative humidity and forming the mixture into a suitable dry unit-dosage pharmaceutical composition.
Dependencies are inferred from the claim text.